Current knowledge on helicobacter pylori infection in end stage renal disease patients.
Gastric infection with Helicobacter Pylori in end-stage renal disease patients is of relevance because of its potential impact on the quality of life as well as morbidity and mortality of patients. Existed data on the issue are controversial, and we attempt in this article to evaluate the available data to approach extended perception of the current knowledge on the epidemiology, relevance, and optimum therapeutic strategies.
Khedmat
Hossein
H
Baqiyatallah Research Center for Gastroenterology and Liver Diseases; Baqiyatallah University of Medical Sciences, Tehran, Iran. Khedmat.h@gmail.com
Taheri
Saeed
S
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000150:complications* / Q000382:microbiology / Q000401:mortality / Q000628:therapy; D016480:Helicobacter pylori / Q000472:pathogenicity*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000401:mortality / Q000628:therapy; D015995:Prevalence; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D011788:Quality of Life; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors